JiangSu WuZhong Pharmaceutical Development Co., Ltd. (SHA:600200)

SHA:600200 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,395	6,565	5,791	5,390	6,038	3,791
Market Cap Growth	-54.68%	13.37%	7.43%	-10.73%	59.29%	-1.01%
Enterprise Value	2,928	6,957	5,975	5,643	6,418	4,276
Last Close Price	1.98	9.32	8.22	7.65	8.57	5.38
PE Ratio	-	93.14	-	-	265.80	-
PS Ratio	0.94	4.11	2.59	2.66	3.40	2.03
PB Ratio	0.76	3.48	3.29	2.96	3.22	2.05
P/TBV Ratio	0.94	4.22	3.56	3.17	3.46	2.12
P/FCF Ratio	-	-	-	370.40	14.28	-
P/OCF Ratio	-	-	-	95.78	13.49	-
EV/Sales Ratio	1.96	4.35	2.67	2.79	3.62	2.29
EV/EBITDA Ratio	43.23	46.27	461.54	307.63	348050.48	543.24
EV/EBIT Ratio	167.55	67.24	-	-	-	-
EV/FCF Ratio	-2.37	-	-	387.78	15.18	-
Debt / Equity Ratio	0.90	0.87	1.00	0.86	0.72	0.70
Debt / EBITDA Ratio	24.09	10.74	126.60	81.21	1314.91	165.16
Debt / FCF Ratio	-	-	-	107.75	3.19	-
Asset Turnover	0.36	0.39	0.54	0.53	0.48	0.49
Inventory Turnover	6.49	8.24	15.44	12.12	9.03	7.02
Quick Ratio	1.26	1.46	1.20	1.39	1.23	1.29
Current Ratio	1.48	1.53	1.26	1.47	1.58	1.68
Return on Equity (ROE)	0.36%	4.22%	-4.15%	-4.23%	1.11%	-24.08%
Return on Assets (ROA)	0.26%	1.56%	-0.48%	-0.46%	-0.82%	-1.24%
Return on Capital (ROIC)	0.31%	1.83%	-0.58%	-0.53%	-0.95%	-1.45%
Return on Capital Employed (ROCE)	0.80%	4.80%	-	-	-	-
Earnings Yield	-0.35%	1.07%	-1.24%	-1.42%	0.38%	-13.36%
FCF Yield	-88.70%	-4.72%	-4.94%	0.27%	7.00%	-12.10%
Payout Ratio	-	96.19%	-	-	275.09%	-
Buyback Yield / Dilution	1.15%	0.05%	0.07%	-0.41%	0.47%	0.53%
Total Shareholder Return	-	0.05%	0.07%	-0.41%	0.47%	0.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.